Patents by Inventor Steven Patrick Rivera

Steven Patrick Rivera has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR DETECTING CYSTIC FIBROSIS
    Publication number: 20210198744
    Abstract: The present invention relates to methods for simultaneously determining the presence or absence of mutations, deletions, duplications and single nucleotide polymorphisms in a cystic fibrosis transmembrane regulator (CFTR) nucleic acid. Oligonucleotide primers and kits used to amplify regions of a CFTR nucleic acid for high throughput, massively parallel sequencing and methods of determining an individual's cystic fibrosis status are also disclosed.
    Type: Application
    Filed: March 15, 2021
    Publication date: July 1, 2021
    Applicant: QUEST DIAGNOSTICS INVESTMENTS LLC
    Inventor: Steven Patrick RIVERA
  • Method for detecting cystic fibrosis
    Patent number: 10947592
    Abstract: The present invention relates to methods for simultaneously determining the presence or absence of mutations, deletions, duplications and single nucleotide polymorphisms in a cystic fibrosis transmembrane regulator (CFTR) nucleic acid. Oligonucleotide primers and kits used to amplify regions of a CFTR nucleic acid for high throughput, massively parallel sequencing and methods of determining an individual's cystic fibrosis status are also disclosed.
    Type: Grant
    Filed: October 12, 2018
    Date of Patent: March 16, 2021
    Assignee: Quest Diagnostics Investments LLC
    Inventor: Steven Patrick Rivera
  • METHOD FOR DETECTING CYSTIC FIBROSIS
    Publication number: 20190100804
    Abstract: The present invention relates to methods for simultaneously determining the presence or absence of mutations, deletions, duplications and single nucleotide polymorphisms in a cystic fibrosis transmembrane regulator (CFTR) nucleic acid. Oligonucleotide primers and kits used to amplify regions of a CFTR nucleic acid for high throughput, massively parallel sequencing and methods of determining an individual's cystic fibrosis status are also disclosed.
    Type: Application
    Filed: October 12, 2018
    Publication date: April 4, 2019
    Applicant: QUEST DIAGNOSTICS INVESTMENTS LLC
    Inventor: Steven Patrick Rivera
  • Method for detecting cystic fibrosis
    Patent number: 10100361
    Abstract: The present invention relates to methods for simultaneously determining the presence or absence of mutations, deletions, duplications and single nucleotide polymorphisms in a cystic fibrosis transmembrane regulator (CFTR) nucleic acid. Oligo nucleotide primers and kits used to amplify regions of a CFTR nucleic acid for high throughput, massively parallel sequencing and methods of determining an individual's cystic fibrosis status are also disclosed.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: October 16, 2018
    Assignee: Quest Diagnostics Investments Incorporated
    Inventor: Steven Patrick Rivera
  • METHOD FOR DETECTING CYSTIC FIBROSIS
    Publication number: 20160032385
    Abstract: The present invention relates to methods for simultaneously determining the presence or absence of mutations, deletions, duplications and single nucleotide polymorphisms in a cystic fibrosis transmembrane regulator (CFTR) nucleic acid. Oligo nucleotide primers and kits used to amplify regions of a CFTR nucleic acid for high throughput, massively parallel sequencing and methods of determining an individual's cystic fibrosis status are also disclosed.
    Type: Application
    Filed: March 14, 2014
    Publication date: February 4, 2016
    Applicant: QUEST DIAGNOSTICS INVESTMENTS INCORPORATED
    Inventor: Steven Patrick Rivera